← Find more feeds

otsuka.com

Otsuka Holdings Co., Ltd. Otsuka Group News RSS

Get the latest updates from Otsuka Holdings Co., Ltd. Otsuka Group News RSS directly as they happen.

Follow now 46 followers

Latest posts

Last updated 1 day ago

Pharmavite Established a New Facility in Ohio, US, Dedicated to The Manufacturing of Gummy Supplements Facilitating the Research and Development of Gummy Products

1 day ago

Read full

Otsuka Signs Joint Research Agreement with Keio University Industry-academia collaboration for infrastructure development toward the social implementation of psychedelics in Japan

2 days ago

Read full

Otsuka Pharmaceutical Factory America, Inc. Acquires 60% Interest in Otsuka ICU Medical LLC and Subsidiarizes

8 days ago

Read full

Otsuka Pharmaceutical Opens First POCARI SWEAT Factory in Vietnam Supporting Health and Meeting Growing Demand

25 days ago

Read full

Otsuka Pharmaceutical is Focusing on "Water, Nutrition, and Oxygen" to Tap into Human Potential Provide "Wellness Energy" at Expo 2025 in Osaka, Kansai, Japan

about 1 month ago

Read full

J.O. Pharma installs electricity from renewable sources to contribute to a decarbonized society

about 1 month ago

Read full

Otsuka Files Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy

about 1 month ago

Read full

Otsuka Holdings appoints Board Members and Auditors and Supervisory Board Members

about 1 month ago

Read full

Announcement of Price Revisions for Oronine H Ointment

about 2 months ago

Read full

Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech

about 2 months ago

Read full

Otsuka Pharmaceutical is Expanding “Local Production and Local Recycling” of PET Bottle Initiatives in Cooperation with Local Communities Agreement Signed with the Saga Eastern Environmental Facilities Association for Horizontal Recycling of PET Bottl

about 2 months ago

Read full

Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older

about 2 months ago

Read full

Or log in

Everything you care about in one place

Otsuka Holdings Co., Ltd. Otsuka Group News RSS

Latest posts

Pharmavite Established a New Facility in Ohio, US, Dedicated to The Manufacturing of Gummy Supplements Facilitating the Research and Development of Gummy Products

Otsuka Signs Joint Research Agreement with Keio University Industry-academia collaboration for infrastructure development toward the social implementation of psychedelics in Japan

Otsuka Pharmaceutical Factory America, Inc. Acquires 60% Interest in Otsuka ICU Medical LLC and Subsidiarizes

Otsuka Pharmaceutical Opens First POCARI SWEAT Factory in Vietnam Supporting Health and Meeting Growing Demand

Otsuka Pharmaceutical is Focusing on "Water, Nutrition, and Oxygen" to Tap into Human Potential Provide "Wellness Energy" at Expo 2025 in Osaka, Kansai, Japan

J.O. Pharma installs electricity from renewable sources to contribute to a decarbonized society

Otsuka Files Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy

Otsuka Holdings appoints Board Members and Auditors and Supervisory Board Members

Announcement of Price Revisions for Oronine H Ointment

Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech

Otsuka Pharmaceutical is Expanding “Local Production and Local Recycling” of PET Bottle Initiatives in Cooperation with Local Communities Agreement Signed with the Saga Eastern Environmental Facilities Association for Horizontal Recycling of PET Bottl

Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older

Try Feeder for free